Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 769 to 771 of 771 entries
Sorted by: Best Match Show Resources per page
A Scoping Review of Non-Medical and Extra-Medical Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

Drug safety

Brennan R, Wazaify M, Shawabkeh H, Boardley I, McVeigh J, Van Hout MC.
PMID: 34331260
Drug Saf. 2021 Sep;44(9):917-928. doi: 10.1007/s40264-021-01085-9. Epub 2021 Jul 30.

Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used medications worldwide and have analgesic, antipyretic and anti-inflammatory properties. Although NSAIDs are recognised as generally safe and effective, non-medical and extra-medical use of these products can occur. Unlike the...

Cite
Brennan R, Wazaify M, Shawabkeh H, et al. A Scoping Review of Non-Medical and Extra-Medical Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Drug Saf. 2021;44(9):917-928doi: 10.1007/s40264-021-01085-9.
Brennan, R., Wazaify, M., Shawabkeh, H., Boardley, I., McVeigh, J., & Van Hout, M. C. (2021). A Scoping Review of Non-Medical and Extra-Medical Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Drug safety, 44(9), 917-928. https://doi.org/10.1007/s40264-021-01085-9
Brennan, Rebekah, et al. "A Scoping Review of Non-Medical and Extra-Medical Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)." Drug safety vol. 44,9 (2021): 917-928. doi: https://doi.org/10.1007/s40264-021-01085-9
Brennan R, Wazaify M, Shawabkeh H, Boardley I, McVeigh J, Van Hout MC. A Scoping Review of Non-Medical and Extra-Medical Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Drug Saf. 2021 Sep;44(9):917-928. doi: 10.1007/s40264-021-01085-9. Epub 2021 Jul 30. PMID: 34331260; PMCID: PMC8370940.
Copy Download .nbib Format: NLM
Perverse Results from Pharmaceutical Patents in the United States.

IIC; international review of industrial property and copyright law

Grimes W.
PMID: 33935295
IIC Int Rev Ind Prop Copyr Law. 2021 Apr 28;1-10. doi: 10.1007/s40319-021-01055-9. Epub 2021 Apr 28.

In the United States, pharmaceutical patents have had a number of perverse and anticompetitive effects on the development and marketing of prescription drugs. Although some of these effects are unique to the United States, others have implications for patent...

Cite
Grimes W. Perverse Results from Pharmaceutical Patents in the United States. IIC Int Rev Ind Prop Copyr Law. 2021;1-10doi: 10.1007/s40319-021-01055-9.
Grimes, W. (2021). Perverse Results from Pharmaceutical Patents in the United States. IIC; international review of industrial property and copyright law, 1-10. https://doi.org/10.1007/s40319-021-01055-9
Grimes, Warren. "Perverse Results from Pharmaceutical Patents in the United States." IIC; international review of industrial property and copyright law vol. (2021): 1-10. doi: https://doi.org/10.1007/s40319-021-01055-9
Grimes W. Perverse Results from Pharmaceutical Patents in the United States. IIC Int Rev Ind Prop Copyr Law. 2021 Apr 28;1-10. doi: 10.1007/s40319-021-01055-9. Epub 2021 Apr 28. PMID: 33935295; PMCID: PMC8079839.
Copy Download .nbib Format: NLM
Sports nutrition supplements and adverse events - a meta-epidemiological study of case reports specifically addressing causality assessment.

European journal of clinical pharmacology

Zeijlon R, Hantelius V, Wallerstedt SM, Holmqvist L.
PMID: 34599661
Eur J Clin Pharmacol. 2022 Jan;78(1):1-9. doi: 10.1007/s00228-021-03223-9. Epub 2021 Oct 02.

PURPOSE: This meta-epidemiological study aimed to systematically review case reports regarding sports nutrition supplements and adverse events (AEs), specifically addressing the issue of causality assessments.METHODS: Through a systematic literature search we identified all published case reports of AEs associated...

Cite
Zeijlon R, Hantelius V, Wallerstedt SM, et al. Sports nutrition supplements and adverse events - a meta-epidemiological study of case reports specifically addressing causality assessment. Eur J Clin Pharmacol. 2021;78(1):1-9doi: 10.1007/s00228-021-03223-9.
Zeijlon, R., Hantelius, V., Wallerstedt, S. M., & Holmqvist, L. (2022). Sports nutrition supplements and adverse events - a meta-epidemiological study of case reports specifically addressing causality assessment. European journal of clinical pharmacology, 78(1), 1-9. https://doi.org/10.1007/s00228-021-03223-9
Zeijlon, Rickard, et al. "Sports nutrition supplements and adverse events - a meta-epidemiological study of case reports specifically addressing causality assessment." European journal of clinical pharmacology vol. 78,1 (2022): 1-9. doi: https://doi.org/10.1007/s00228-021-03223-9
Zeijlon R, Hantelius V, Wallerstedt SM, Holmqvist L. Sports nutrition supplements and adverse events - a meta-epidemiological study of case reports specifically addressing causality assessment. Eur J Clin Pharmacol. 2022 Jan;78(1):1-9. doi: 10.1007/s00228-021-03223-9. Epub 2021 Oct 02. PMID: 34599661; PMCID: PMC8724217.
Copy Download .nbib Format: NLM
Showing 769 to 771 of 771 entries